| Journal Article |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| A Computationally Efficient Method for Probabilistic Parameter Threshold Analysis for Health Economic Evaluations |
0 |
0 |
0 |
0 |
1 |
1 |
7 |
11 |
| Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Models |
1 |
1 |
2 |
5 |
2 |
4 |
14 |
30 |
| Assessing the role of children in the COVID-19 pandemic in Belgium using perturbation analysis |
0 |
0 |
0 |
0 |
0 |
1 |
8 |
8 |
| Authors’ Reply to Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine” |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
5 |
| COVID-19 and retail: The catalyst for e-commerce in Belgium? |
1 |
2 |
3 |
20 |
1 |
7 |
24 |
92 |
| Comparative analysis of the impact of chickenpox and herpes zoster vaccination in Belgium under two different exogenous boosting mechanisms |
0 |
0 |
0 |
0 |
0 |
2 |
2 |
2 |
| Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine |
0 |
1 |
1 |
2 |
0 |
1 |
2 |
10 |
| Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver(s) and ``No Medical Care'' Disease Impact in Belgium |
0 |
0 |
0 |
0 |
0 |
1 |
5 |
6 |
| Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries |
0 |
0 |
1 |
3 |
0 |
3 |
11 |
21 |
| Data mining for longitudinal data under multicollinearity and time dependence using penalized generalized estimating equations |
0 |
0 |
0 |
7 |
1 |
2 |
10 |
57 |
| Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
4 |
| Do costs of varicella justify routine infant vaccination? |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
11 |
| Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
16 |
| Economic Evaluations of Childhood Influenza Vaccination |
0 |
0 |
0 |
4 |
1 |
1 |
9 |
74 |
| Economic Evaluations of Varicella Vaccination Programmes |
0 |
0 |
0 |
18 |
0 |
3 |
7 |
190 |
| Economic evaluations of hepatitis B immunization: a global review of recent studies (1994–2000) |
0 |
0 |
0 |
51 |
0 |
1 |
4 |
184 |
| Effectiveness of a Malaria Surveillance Strategy Based on Active Case Detection during High Transmission Season in the Peruvian Amazon |
0 |
0 |
0 |
0 |
0 |
3 |
7 |
14 |
| Estimating infectious disease parameters from data on social contacts and serological status |
0 |
0 |
0 |
24 |
0 |
0 |
7 |
110 |
| Estimating the Incidence of Symptomatic Rotavirus Infections: A Systematic Review and Meta-Analysis |
0 |
0 |
0 |
0 |
0 |
1 |
6 |
9 |
| Estimation of the Force of Infection from Current Status Data Using Generalized Linear Mixed Models |
0 |
0 |
0 |
65 |
0 |
0 |
5 |
245 |
| Evolutions in Both Co-Payment and Generic Market Share for Common Medication in the Belgian Reference Pricing System |
0 |
0 |
0 |
1 |
0 |
2 |
7 |
42 |
| Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better Practice |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
3 |
| Individual decisions to vaccinate one's child or oneself: A discrete choice experiment rejecting free-riding motives |
0 |
0 |
0 |
2 |
0 |
1 |
7 |
32 |
| Influenza-Like-Illness and Clinically Diagnosed Flu: Disease Burden, Costs and Quality of Life for Patients Seeking Ambulatory Care or No Professional Care at All |
0 |
0 |
0 |
0 |
1 |
3 |
10 |
13 |
| Medicine price awareness in chronic patients in Belgium |
0 |
0 |
0 |
4 |
0 |
3 |
8 |
38 |
| Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community |
0 |
0 |
0 |
2 |
1 |
6 |
10 |
29 |
| Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community |
0 |
0 |
0 |
4 |
1 |
5 |
14 |
46 |
| Modelling forces of infection by using monotone local polynomials |
0 |
0 |
0 |
14 |
0 |
1 |
5 |
69 |
| Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern |
0 |
0 |
0 |
46 |
0 |
2 |
15 |
238 |
| Public preferences over efficiency, equity and autonomy in vaccination policy: An empirical study |
0 |
0 |
0 |
8 |
0 |
2 |
12 |
45 |
| Recent quantitative research on determinants of health in high income countries: A scoping review |
0 |
0 |
0 |
0 |
1 |
5 |
8 |
18 |
| Revealing age-specific past and future unrelated costs of pneumococcal infections by flexible generalized estimating equations |
0 |
0 |
0 |
1 |
1 |
4 |
13 |
57 |
| Reviewing the Cost Effectiveness of Rotavirus Vaccination |
0 |
0 |
0 |
30 |
0 |
4 |
8 |
149 |
| Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases |
0 |
0 |
0 |
2 |
2 |
3 |
17 |
48 |
| Social preferences for adopting new vaccines in the national immunization program: A discrete choice experiment |
0 |
0 |
0 |
1 |
0 |
4 |
15 |
17 |
| Sponsorship Bias in Base-Case Values and Uncertainty Bounds of Health Economic Evaluations? A Systematic Review of Herpes Zoster Vaccination |
0 |
0 |
1 |
1 |
0 |
2 |
8 |
25 |
| The Cost of Arbovirus Disease Prevention in Europe: Area-Wide Integrated Control of Tiger Mosquito, Aedes albopictus, in Emilia-Romagna, Northern Italy |
0 |
0 |
1 |
2 |
0 |
1 |
10 |
15 |
| The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach |
0 |
0 |
0 |
0 |
0 |
1 |
7 |
7 |
| The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19 |
0 |
0 |
0 |
1 |
0 |
0 |
3 |
7 |
| The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands |
0 |
0 |
1 |
103 |
0 |
3 |
20 |
279 |
| The possible macroeconomic impact on the UK of an influenza pandemic |
0 |
0 |
0 |
137 |
1 |
8 |
22 |
737 |
| Understanding the Cost-Effectiveness of Influenza Vaccination in Children: Methodological Choices and Seasonal Variability |
0 |
0 |
0 |
8 |
0 |
2 |
3 |
45 |
| Total Journal Articles |
2 |
4 |
10 |
566 |
14 |
95 |
363 |
3,058 |
LogEc is hosted by the
Örebro University School of Business.